CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 683954-684086
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T1973","span":{"begin":0,"end":132},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, the safety of fexofenadine has been demonstrated in pediatric subjects 2 to 5 years of age with allergic rhinitis (AR)."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T67","span":{"begin":0,"end":132},"obj":"Sentence"}],"text":"In addition, the safety of fexofenadine has been demonstrated in pediatric subjects 2 to 5 years of age with allergic rhinitis (AR)."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6299","span":{"begin":109,"end":126},"obj":"Disease"},{"id":"T6300","span":{"begin":109,"end":117},"obj":"Disease"},{"id":"T6301","span":{"begin":118,"end":126},"obj":"Disease"},{"id":"T6302","span":{"begin":128,"end":130},"obj":"Disease"}],"attributes":[{"id":"A6299","pred":"mondo_id","subj":"T6299","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"id":"A6300","pred":"mondo_id","subj":"T6300","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A6301","pred":"mondo_id","subj":"T6301","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"},{"id":"A6302","pred":"mondo_id","subj":"T6302","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"}],"text":"In addition, the safety of fexofenadine has been demonstrated in pediatric subjects 2 to 5 years of age with allergic rhinitis (AR)."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T3397","span":{"begin":109,"end":126},"obj":"Phenotype"},{"id":"T3398","span":{"begin":128,"end":130},"obj":"Phenotype"}],"attributes":[{"id":"A3397","pred":"hp_id","subj":"T3397","obj":"http://purl.obolibrary.org/obo/HP_0003193"},{"id":"A3398","pred":"hp_id","subj":"T3398","obj":"http://purl.obolibrary.org/obo/HP_0003193"}],"text":"In addition, the safety of fexofenadine has been demonstrated in pediatric subjects 2 to 5 years of age with allergic rhinitis (AR)."}